Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
Karoline von Websky, Christoph Reichetzeder, Berthold Hocher Institute of Nutritional Science, University of Potsdam, Potsdam-Rehbrücke, Germany Abstract: Type 2 diabetes mellitus (T2DM) is a highly prevalent, progressive disease that often is poorly controlled. The combination of an incret...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-11-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/linagliptin-as-add-on-therapy-to-insulin-for-patients-with-type-2-diab-a14871 |